Watch Demo

South Africa Antidiabetics Industry Outlook 2022 - 2026

See how South Africa Antidiabetics performed compared to key markets such as Germany, France and Italy.

Key Market Indicators

The country was 15th in 2021, China came ahead with $55,399,000. Germany, India and the Netherlands respectively were numbers 2, 3 and 4 in this ranking. South Africa is set to become a major player in the insulin export and import market over the next few years. Export is expected to reach nearly $855 million by 2026, up from $782 million in 2021. This represents an annual growth rate of 1.4%. Since 2005, exports have increased by 10.9% each year. In 2021, South Africa was the 33rd largest exporter of insulin, behind the Netherlands, which exported $782 million. France, Italy and China came in second, third and fourth respectively. Meanwhile, imports are set to reach $60.1 billion by 2026, up from $55.4 billion in 2021. This represents an annual growth rate of 1.3%. Since 2005, imports have increased by 3.6% each year. In 2021, South Africa was the 15th largest importer of insulin, behind China, which imported $55.4 billion. Germany, India and the Netherlands came in second, third and fourth respectively.

Marketing Banner

South Africa Antidiabetics Market Data and Forecasts

How much will South Africa Antidiabetics Market grow to 2026?

Forecast: Insulin in Dosage Market Size Value Per Capita in South Africa
Forecast: Insulin in Dosage Market Size Value in South Africa
Forecast: Export of Insulin in Dosage Forms from South Africa
Forecast: Import of Insulin Not in Dosage Forms to South Africa
Forecast: Export of Insulin in Dosage Forms from South Africa
More in Antidiabetics Industry for 2028